Search Results

Darunavir/cobicistat showing similar effectiveness as darunavir/ ritonavir monotherapy despite lower trough concentrations.

• Authors : Gutierrez‐Valencia, Alicia; Trujillo‐Rodriguez, Maria; Fernandez‐Magdaleno, Tamara

Subjects: COMBINATION drug therapy; DARUNAVIR; RITONAVIR

• Source: Journal of the International AIDS Society; Feb2018, Vol. 21 Issue 2, p1-N.PAG, 6p, 2 Charts, 1 Graph

Record details

Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?

• Authors : Vitoria, Marco; Hill, Andrew M; Ford, Nathan P

Subjects: ANTIRETROVIRAL agents; TENOFOVIR; DRUG formularies

• Source: Journal of the International AIDS Society; 2016, Vol. 19 Issue 1, p1-N.PAG, 9p, 6 Charts

Record details

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor.

• Authors : Fisher, Martin; McDonald, Cheryl; Moyle, Graeme

Subjects: RITONAVIR; HIV-positive persons; KIDNEY failure

• Source: Journal of the International AIDS Society; Nov2014 Supplement 4S3, Vol. 17, pn/a-n/a, 1p

Record details

Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review.

• Authors : O'Rourke, John; Townsend, Claire L.; Milanzi, Edith

Subjects: HIV-positive teenagers; CLINICAL trial registries; BONE density

• Source: Journal of the International AIDS Society; Feb2023, Vol. 26 Issue 2, p1-14, 14p, 1 Diagram, 4 Charts, 2 Graphs

Record details

Weight gain before and after switch from TDF to TAF in a U.S. cohort study.

• Authors : Mallon, Patrick WG; Brunet, Laurence; Hsu, Ricky K

Subjects: WEIGHT gain; NON-nucleoside reverse transcriptase inhibitors; CD4 lymphocyte count

• Source: Journal of the International AIDS Society; Apr2021, Vol. 24 Issue 4, p1-9, 9p, 2 Charts, 3 Graphs

Record details

Phase IIIb, open-label single-arm trial of darunavir/cobicistat (DRV/COBI): Week 48 subgroup analysis of HIV-1-infected treatment-nave adults.

• Authors : Tashima, Karen; Crofoot, Gordon; Tomaka, Frank L

Subjects: DARUNAVIR; HIV-positive persons; HIV infections

• Source: Journal of the International AIDS Society; Nov2014 Supplement 4S3, Vol. 17, pn/a-n/a, 1p

Record details

Abstract Supplement HIV Glasgow 10–13 November 2024, Glasgow, UK/Virtual.

Subjects: SEXUALLY transmitted diseases; HIV-positive persons; MENTAL illness

• Source: Journal of the International AIDS Society; Nov2024 Supplement 1, Vol. 27, p1-353, 353p

Record details

Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis.

• Authors : Yoo, Jeong‐Ju; Jung, Eun Ae; Kim, Sang Gyune

Subjects: HIV-positive persons; BODY mass index; ANTIRETROVIRAL agents

• Source: Journal of the International AIDS Society; Sep2024, Vol. 27 Issue 9, p1-18, 18p

Record details

Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices.

• Authors : Radix, Asa; Sevelius, Jae; Deutsch, Madeline B

Subjects: TRANS women; TRANSGENDER people; HIV-positive persons

• Source: Journal of the International AIDS Society; Jul2016 Supplement 3S2, Vol. 19, pn/a-n/a, 8p, 3 Charts

Record details

The challenge of HIV treatment in an era of polypharmacy.

• Authors : Back, David; Marzolini, Catia

Subjects: DRUG side effects; HIV infections; MEDICATION reconciliation

• Source: Journal of the International AIDS Society; Feb2020, Vol. 23 Issue 2, p1-12, 12p, 2 Diagrams, 5 Charts, 1 Graph

Record details